Q-omics provides the consensus-scored RNU4-12P profile across patient tissues and cancer cell-line models. RNU4-12P expression is associated with patient survival in 6 of 34 cancer types, with the highest sampling consensus in KIRP. Additionally, RNU4-12P RNA expression shows 3,912 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight KIRP, and STAD as cancer lineages where RNU4-12P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.